Diabetes Pharmacists Role

COMPLICATIONS OF TYPE 2 DIABETES MELLITUS (T2DM): DIABETIC KIDNEY DISEASE

Introduction

Kidney disease is one of the most common complications of both type 1 and type 2 diabetes mellitus (T2DM): an estimated 40% of people with diabetes will develop diabetic kidney disease* (DKD) during their lifetime.1 Pharmacists have the potential to contribute to the multidisciplinary team providing safe, effective and economic care of people with DKD, through medication reviews, optimising medication use, and providing counselling to patients to improve adherence.2
*Diabetic kidney disease (DKD) or diabetic nephropathy refers to chronic kidney disease (CKD) caused by diabetes

Learning objectives

On completion of this module, you will have a better understanding of:

  • The prevalence of DKD
  • Clinical implications of DKD
  • The importance of early recognition of DKD
  • Management of DKD and the role of pharmacists

Section 1. Prevalence of diabetic kidney disease

Section 2. Clinical implications of diabetic kidney disease

Section 3. The importance of early recognition of diabetic kidney disease

Section 4. Management of diabetic kidney disease

Section 5. Reflection

Click ‘Start’ to open the CPD module

After completion of the module the reflection document can be filled in and printed out for your personal development plan. This can be presented at annual appraisal or revalidation. The downloaded module includes the completion stamp showing 30 minutes self -directed CPD undertaken.

START MODULE

Job Code: UK-DIAB-2000054 DOP: December 2020

References

  1. Couser WG, Remuzzi G, Mendis S, et al. The contribution of chronic kidney disease to the global burden of major non-communicable diseases. Kidney Int 2011;80(12):1258-70
  2. al Raiisi F, Stewart D, Fernandez-Llimos F, et al. Clinical pharmacy practice in the care of chronic kidney disease patients: a systematic review. Int J Clin Pharm 2019;41(3):630-666